Welcome to our dedicated page for QT Imaging Holdings news (Ticker: QTIH), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
QT Imaging Holdings (QTIH) delivers innovative medical imaging solutions through advanced diagnostic technology. This news hub provides investors and healthcare professionals with essential updates on the company's developments in non-invasive imaging systems and strategic initiatives.
Access timely press releases covering quarterly earnings, new product approvals, research breakthroughs, and partnership announcements. Our curated collection ensures you stay informed about QTIH's progress in enhancing diagnostic accuracy and expanding clinical applications of its imaging platforms.
Key updates include regulatory milestones, technology licensing agreements, and peer-reviewed study results. Bookmark this page for direct access to original source materials and analysis-free reporting on QTIH's contributions to medical imaging advancements.
QT Imaging Holdings (OTCQB: QTIH) has launched QTviewer 2.8, an enhanced version of its medical imaging software that complements their FDA-cleared QTI Breast Acoustic CT scanner. The new version introduces significant improvements including stateless DICOM viewing, real-time lesion doubling time analysis, and advanced RGB visualization modes.
The software update features improved multi-series comparison capabilities, optimized viewport layouts, and secure enterprise license management. Notable enhancements include automatic image type recognition and streamlined workflow processes. This release follows the recent introduction of image reconstruction software v4.4.0, which significantly reduced QTscan processing time.
QT Imaging Holdings (OTCQB: QTIH) has announced two key leadership appointments to strengthen its medical and clinical capabilities. Dr. Elaine Iuanow, a board-certified breast radiologist with over 20 years of experience, joins as Chief Medical Officer, while Kim Du becomes Senior Director of Clinical Operations.
The appointments support QTI's expansion of clinical studies and development of AI-driven lesion classification and second-read decision support tools for its FDA-cleared QTI Breast Acoustic CT™ scanner. The technology aims to provide an alternative to MRI, particularly beneficial for the 50% of U.S. women aged 40-74 with dense breast tissue.
The company is focusing on transforming into a precision imaging AI company, with plans to conduct multi-center clinical trials studying their technology as an MRI alternative for high-risk women and breast cancer management.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has announced its 2025 Annual Meeting of Stockholders. The meeting will be held virtually on August 19, 2025, at 1:00 p.m. EDT.
Stockholders of record as of July 16, 2025 will be eligible to vote at the meeting. Detailed information about the virtual meeting access and participation instructions will be provided in the upcoming proxy statement and made available on the company's investor relations website.
QT Imaging Holdings (OTCQB:QTIH) has released version 4.4.0 of its image reconstruction software for the FDA-cleared QTscan™ Breast Acoustic CT™ scanner. The update, powered by NVIDIA's L40 GPU with Ada Lovelace architecture, significantly reduces image processing time while maintaining diagnostic accuracy and image quality comparable to MRI.
The QTscan™ technology provides non-invasive 3D breast imaging without compression, contrast agents, or ionizing radiation. The software update ensures minimal downtime and seamless workflow integration, enhancing scalability for breast imaging centers with increasing patient volumes. The company continues to develop machine learning algorithms to improve both processing and scanning times.
QT Imaging Holdings (OTCQB:QTIH) has successfully delivered and installed its QT Imaging Breast Acoustic CT™ Scanner at Innovative Radiology in Des Moines, Iowa, marking the first installation of this technology in the state. The scanner utilizes proprietary low-frequency ultrasound technology to create high-resolution, 3D breast images without using ionizing radiation or compression, making it particularly beneficial for patients with dense breast tissue.
Led by Dr. John Tentinger, Innovative Radiology becomes the first facility in Iowa to offer this advanced imaging solution alongside their existing suite of diagnostic technologies, including mammography, MRI, CT, ultrasound, and X-ray. The installation represents a significant step in expanding access to radiation-free breast imaging technology in the region.
QT Imaging Holdings (OTCQB:QTIH), a medical device company focused on body imaging systems, has secured a $200,000 PIPE investment from Mr. Leon Recanati, vice chairman of Israel Cancer Association. The investment terms include the purchase of 205,339 unregistered common stock shares at $0.974 per share, representing a 10% premium to the 5-day VWAP as of May 9, 2025. The deal also includes 205,339 warrants with an exercise price of $1.12 per share.
The transaction, expected to close by May 19, 2025, was placed directly by the company without banking fees. The proceeds will be used as working capital to support business growth.
QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu have agreed to purchase 784,929 unregistered common stock shares at $0.637 per share, representing a 10% premium to the volume weighted average trading price on April 9, 2025.
The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.
QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. The investment comes from Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu, who agreed to purchase 784,929 unregistered common stock shares at $0.637 per share on April 9, 2025.
The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The share price represents a 10% premium to the company's volume weighted average trading price. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.
QT Imaging Holdings (OTCQB:QTIH) has announced its participation in the 2025 SBI Breast Imaging Symposium, scheduled for April 24-27 in Colorado Springs, Colorado. The company will showcase its innovative QT Breast Acoustic CT™ imaging technology at Canon Medical Systems' booth 535.
The technology represents a significant advancement in breast imaging, offering radiation-free and highly accurate breast scans. It is specifically designed to improve early detection of breast abnormalities and enhance patient outcomes, with particular effectiveness for women with dense breast tissue.
Dr. Bilal Malik, Chief Science Officer, emphasized the company's commitment to engaging with healthcare professionals and demonstrating how their technology aims to transform breast imaging practices globally. The company maintains its focus on advancing women's healthcare through innovative technologies and strategic partnerships.
FAQ
What is the current stock price of QT Imaging Holdings (QTIH)?
What is the market cap of QT Imaging Holdings (QTIH)?
